Oxford Nanopore JPM Presentation Thoughts

Oxford Nanopore’s JPM slides are now available and add some color to the interim results previously posted.

As before they claim 31% underlying revenue growth by throwing out the Emirati Genome Project and COVID applications. The problem with removing large customers, that they are often a large chunk of revenue. And large customers naturally come and go as projects wrap up.

It also seems like much of the new revenue growth could be coming from a single new large customer? Let’s take a look!